Samantha DiGrande

A recent study conducted in Finland and published in Acta Dermatologica-Venerology finds that rosacea could be related to underlying systemic inflammation.

In 2017, The American Journal of Managed Care® (AJMC®) covered conferences on a range of topics: oncology, diabetes, managed care, and much more. however, the most-read coverage from conferences that AJMC® attended mostly focused on cardiology trial results, particularly the cardiovascular results of diabetes medications.

Today, the FDA approved nivolumab (Opdivo, Bristol-Myers Squibb) for the adjuvant treatment of patients with melanoma that has involvement of lymph nodes or metastatic disease, and who have undergone complete resection.

Fresenius Kabi, a subsidiary of the German-based Fresenius SE and Co. KFaA, announced earlier this week that upon completion of its phase 3 study, AURIEL-Psoriasis, it has submitted a Marketing Authorization Application for MSB11022, an adalimumab (Humira, AbbVie) biosimilar candidate to the European Medicines Agency (EMA).

Pfizer announced yesterday the initiation of a phase 3 trial for its once-daily Janus kinase 1- (JAK1) selective inhibitor, PF-04965842, to evaluate the safety and efficacy of the drug for the treatment of moderate to severe atopic dermatitis (AD).

A systematic review of biologics used in to treat palmoplantar psoriasis and palmoplantar pustulosis, 2 diseases that affect the palms and the soles of feet, found several available biologics are at least 80% effective in 1 form of the disease, but that there is less data on how well these drugs work on other forms of the disease.

A recent study in The American Journal of Clinical Dermatology led by Igor Snast, MD, sought to evaluate the efficacy and safety of biologic agents in the treatment of atopic dermatitis (AD). The results of the study showed that in particular, dupilumab stood out.

A new study published Monday by scientists at the University of Massachusetts Medical School (UMMS) in Boston reports findings on a gene that is responsible for creating a protein that may help melanoma to grow and metastasize.

A study published Thursday in JAMA Oncology found that improvements in survival among California cancer patients were almost exclusively limited to patients with private or Medicare insurance.

A recent study indicates that parents are able to take high-quality photos of their child's skin condition to send to a dermatologist for an accurate diagnosis.

A meta-analysis finds a connection between atopic dermatitis and occupational hand eczema.

Behavioral testing of adolescents identified 3 distinct subgroups, suggesting there is not a clear-cut explanation for the disorder.